Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer By Washington Examiner FacebookTwitterWhatsAppLinkedinEmailPrint May 19, 2014 6:46 am FacebookTwitterWhatsAppLinkedinEmailPrint LONDON (AP) — Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer. Recommended Stories Late-night host Jimmy Kimmel melts down at JD Vance for mocking his ratingsJimmy Fallon defends show as nonpartisan: ‘We try to make everybody laugh’California's Native American tribes use political power to push out business rivals TagsMergers and AcquisitionsPfizerUnited Kingdom Related Content Business Late-night host Jimmy Kimmel melts down at JD Vance for mocking his ratings White House White House yanks Brian Quintenz nomination to head Commodity Futures Trading Commission Business Jimmy Fallon defends show as nonpartisan: ‘We try to make everybody laugh’ Senate Senate rejects dueling funding bills, teeing up government shutdown at midnight News Soros-backed group behind ‘No Kings’ protests pressuring Senate Democrats into government shutdown
